chr11-534289-C-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_ModeratePP5_Moderate
The NM_005343.4(HRAS):c.34G>C(p.Gly12Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G12E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_005343.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HRAS | ENST00000311189.8 | c.34G>C | p.Gly12Arg | missense_variant | Exon 2 of 6 | 1 | NM_005343.4 | ENSP00000309845.7 | ||
HRAS | ENST00000417302.7 | c.34G>C | p.Gly12Arg | missense_variant | Exon 2 of 6 | 5 | NM_176795.5 | ENSP00000388246.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Costello syndrome Pathogenic:1
Variant summary: HRAS c.34G>C (p.Gly12Arg) results in a non-conservative amino acid change located in the Small GTP-binding protein domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250294 control chromosomes. c.34G>C has been reported in the literature in at least one individual with precocious puberty in mosaic state and in a large number of tumor samples in somatic state. At least one publication reports experimental evidence evaluating an impact on protein function and showed that this variant resulted in increased potency in focus induction and cell growth. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant in germline to ClinVar after 2014. However, many other variants affecting Gly12 have been classified as pathgoenic by our laboratories and other clinical laboratories. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at